Beijing Dongfang Baitai Biotechnology Co., Ltd
Beijing, China · en.east-bt.com
GMP
On your own
Free. Their own form.
Through Midgard
Midgard sends your request to the lab and keeps the order's messages, papers and payments in one place. Free to ask. 1% platform fee if you keep the order on Midgard.
Beijing Dongfang Baitai Biotechnology Co., Ltd. is a biopharmaceutical company in Beijing engaged in the research, development, production, and sales of innovative biological drugs. It works on antibody-based medicines for malignant tumors, diabetes, autoimmune diseases, and other major diseases. The company is located in Beijing Economic-Technological Development Area and operates a research and industrialization platform for antibody therapeutics.
Their website has a general contact form; we send your quote request through it.
What they offer
Antibody drug R&D
Researches innovative antibody therapeutics across the drug discovery and development process.
Monoclonal antibody development
Develops monoclonal antibodies for therapeutic use.
Bispecific antibody development
Develops bispecific antibody drugs for disease treatment.
Antibody fusion protein development
Develops antibody fusion protein drugs.
ADC development
Develops antibody-drug conjugates for therapeutic applications.
Antibody humanization
Uses sequence alignment and structural homology modeling to generate humanized antibodies.
High-affinity antibody screening
Uses phage-display screening to identify high-affinity antibody molecules.
Engineered cell line construction
Builds high-expression engineered cell lines for antibody production and process development.
Process optimization
Supports antibody process optimization for manufacturing and scale-up.
Quality management
Manages drug quality across discovery, pharmacology and toxicology, process development, clinical trials, and production.
What they work on
- Modalities
- Antibody, Bispecific, ADC, Recombinant protein, Vaccine
- Species and models
- animal disease models
- Assays and studies
- phage-display screening, antibody humanization, three-dimensional structural homology modeling, QbD-based quality management
- Instruments and platforms
- cutting-edge analytical techniques
- Scale and capacity
- 3 × 2000L mammalian cell batch culture and purification production line, 30 mu first-phase site, more than 100 people team
- Therapeutic areas
- malignant tumors, diabetes, autoimmune diseases, ophthalmic diseases, respiratory diseases, rheumatoid arthritis, psoriasis, ankylosing spondylitis, nasopharyngeal cancer
- Sites
- Beijing, China
- Team
- more than 100 people
- Quality
- GMP (China, European Union, and FDA) · ISO 9000 · NMPA regulatory guidelines · ICH · FDA regulations · QbD
- Serves
- China, international
- Founded
- 2011
Similar labs. GlycoNex, Inc., Probiocdmo, Sparx BIO, Transcenta Holding
Found in a contract services directory. Listing built from en.east-bt.com. Work here? Claim this listing.